|
Fluids in Septic Shock (FISSH): a randomized controlled trial.
|
Ongoing
|
Normal Saline & Ringer's Lactate
|
3
|
2211076
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
Extra-corporeal membrane oxygenation plus Tocilizimub in treatment of COVID-19
|
Ongoing
|
TOCILIZUMAB
|
3
|
RC20/225/R
|
King Abdulaziz Medical City NG (Riyadh)
|
|
Extra-corporeal membrane oxygenation plus Tocilizimub in treatment of COVID-19
|
Ongoing
|
TOCILIZUMAB
|
3
|
RC20/225/R
|
King Abdulaziz Medical City NG (Riyadh)
|
|
Extending molecular responeses with Nilotinib in newly diagnosed chronic myeloid leukemia (CML) patients in chronic phase (ENESTxtnd)
|
Completed
|
Nilotinib
|
3b
|
CAMN107E2401
|
KFSH
|
|
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC): A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial of MST-188 (Purified Poloxamer 188) Injection in Subjects With Sickle Cell Disease Experiencing Vaso Occlusive Crisis
|
Ongoing
|
Purified Poloxamer 188
|
3
|
MST-188-01
|
KKUH
|
|
Escalating Dose and Randomized, Controlled Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy
|
Ongoing
|
Nusinersen (Spinraza)
|
3
|
232SM203
|
King Fahad Specialist Hospital (Dammam)
|
|
Efficacy of Topical Delivery of Vitamin D3: A phase II Study.
|
Rejected
|
vitamin D3
|
2
|
IRB-2014-01-157
|
KFUH
|
|
Efficacy Of Single Dose Rituximab and Mycophenolate Versus Two Doses Rituximab in Children with Steroid Dependent and Frequent Relapsing Nephrotic Syndrome: Randomized Open-Labeled Pilot Trial
|
Completed
|
Rituximab / Mycophenolate
|
2
|
2020-99
|
KFSH&RC-J
|
|
Efficacy of lntra-cervical Misoprostol in the Management of Early Pregnancy Failure: Randumized Clinical Trial
|
On Hold
|
Misoprostol
|
3
|
227-15
|
KAUH-J
|
|
Efficacy and Safety of Long-Term (6 Months) Innohep® Treatment Versus Anticoagulation With a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patients
|
Completed
|
Innohep (Tinzaparin) VS. Warfarin
|
3
|
IN 0901 INT
|
NGHA-R
|
